Sleep Apnea

Respiratory·MeSH: Sleep Apnea, Obstructive

10 drugs in development·9 companies·3 clinical trials

Drug Pipeline by Phase

Approved(4)

Drug	Company
inspire system	Inspire Medical Systems Inc. (INSP)
pitolisant	Viatris Inc (VTRS)
Sunosi	Axsome Therapeutics, Inc. (AXSM)
Zepbound	ELI LILLY & Co (LLY)

Phase 2(4)

Drug	Company
danavorexton	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
danavorexton	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
Eloralintide	ELI LILLY & Co (LLY)
lorundrostat	Mineralys Therapeutics, Inc. (MLYS)

Phase 1(1)

Drug	Company
maridebart cafraglutide	AMGEN INC (AMGN)

Phase 2/Phase 3(1)

Drug	Company
ihl-42x	Incannex Healthcare Inc. (IXHL)

BioSniper tracks 10 drugs in development for Sleep Apnea across 9 companies.

There are 3 clinical trials targeting Sleep Apnea tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.